Dashboard
Poor Management Efficiency with a low ROE of 7.45%
- The company has been able to generate a Return on Equity (avg) of 7.45% signifying low profitability per unit of shareholders funds
Poor long term growth as Net Sales has grown by an annual rate of 7.26% and Operating profit at 13.42% over the last 5 years
Stock is technically in a Bearish range
With ROE of 10.4, it has a Very Expensive valuation with a 2.1 Price to Book Value
Despite the size of the company, domestic mutual funds hold only 0.04% of the company
Underperformed the market in the last 1 year
Stock DNA
Industrial Products
INR 967 Cr (Micro Cap)
20.00
33
0.00%
-0.29
10.38%
2.14
Total Returns (Price + Dividend) 
Borosil Scienti. for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Borosil Scientific Ltd is Rated Sell
Borosil Scientific Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 November 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Borosil Scientific Ltd Faces Bearish Momentum Amid Technical Downturn
Borosil Scientific Ltd, a micro-cap player in the Industrial Products sector, has experienced a notable shift in its technical momentum, prompting a downgrade in its MarketsMojo Mojo Grade from Hold to Sell as of 3 September 2026. The stock’s recent price action and technical indicators signal a bearish trend, reflecting growing investor caution amid subdued returns and weakening momentum.
Read More
Borosil Scientific Ltd Sees Mixed Technical Signals Amid Mildly Bearish Momentum
Borosil Scientific Ltd, a micro-cap player in the Industrial Products sector, has experienced a nuanced shift in its technical momentum, reflected in a recent upgrade from a Hold to a Sell rating by MarketsMOJO. Despite a notable 4.26% rise in the stock price on 16 Nov 2026, the underlying technical indicators suggest a complex outlook with a transition from bearish to mildly bearish trends across multiple timeframes.
Read More Announcements 
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
28-Oct-2026 | Source : BSEIntimation under Regulation 30 of the SEBI Listing Regulations
Board Meeting Outcome for Outcome Of The Board Meeting Held On October 28 2026
28-Oct-2026 | Source : BSEOutcome of the Board Meeting Held on October 28 2026
Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Half Year Ended September 30 2026
28-Oct-2026 | Source : BSEOutcome of the Board Meeting
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 1 Schemes (0.01%)
Held by 7 FIIs (0.14%)
Kiran Kheruka (25.52%)
Investor Education And Protection Fund Authority Ministry Of Corporate Affairs (2.18%)
22.61%
Quarterly Results Snapshot (Consolidated) - Sep'26 - QoQ
QoQ Growth in quarter ended Sep 2026 is 7.69% vs -25.44% in Jun 2026
QoQ Growth in quarter ended Sep 2026 is 21.51% vs -83.94% in Jun 2026
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is -1.90% vs 15.21% in Sep 2024
Growth in half year ended Sep 2025 is -109.18% vs 62.32% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 5.16% vs 10.41% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -59.13% vs 27.14% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 6.58% vs 10.74% in Mar 2025
YoY Growth in year ended Mar 2026 is 29.14% vs 13.75% in Mar 2025